Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Sirona Biochem Corp V.SBM

Alternate Symbol(s):  SRBCF

Sirona Biochem Corp. is a cosmetic ingredient and drug discovery company with proprietary platform developed at its laboratory facility in France. Through its wholly owned subsidiary TFChem S.A.R.L., the Company specializes in stabilizing carbohydrate molecules. The principal activities of the Company include development of cosmetic and pharmaceutical active ingredients. TFChem develops and markets its GlycoMim technology for pharmaceutical and biotechnology comp anies. TFChem’s proprietary chemistry technology can be applied to the development of several pharmaceutical domains such as cancer, diabetes, pain and inflammation and cardio-vascular diseases. Its cosmetic therapeutic area includes skincare-dark spot corrector (Rx & OTC), cell preservation and repair (including keloid and scar therapy), skincare-anti aging/anti-wrinkle and skincare-cellulite treatment. It has developed an active ingredient, TFC-1067 for the treatment of Dyschromia (Dark spots on the skin).


TSXV:SBM - Post by User

Comment by Ticklel1ston Dec 02, 2021 8:43pm
85 Views
Post# 34192898

RE:RE:RE:RE:RE:RE:December report

RE:RE:RE:RE:RE:RE:December report BIOran. So, China is not at stage 3 yet. When they get to 3 they pay another 1.5 Million? It's taken 7 years to get to stage 2 and let's say they make stage 3 in 2022 baring any chinese new year delays or other excuses management can come up with. So, logic says that at every 2 stages completed they pay 1.5. Sound about right? & years and the get about 30% of the 9.5 million.

 Fruck, it's been 7 years and they haven't complete the second yet. At 7 years for every 3 million payout is going to take another 14 years or so to get the 9.5!!

This does not look like it will be in my life time. Heck, the whole management team could be gone.

Howhee...do you care to comment on my math? Like maybe you can spin the remaining  payout in maybe 10 years?
<< Previous
Bullboard Posts
Next >>